IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $6,421,000 | +77.2% | 75,507 | -26.2% | 0.02% | +11.1% |
Q2 2020 | $3,624,000 | +145.9% | 102,246 | -6.5% | 0.02% | +200.0% |
Q1 2020 | $1,474,000 | -33.9% | 109,345 | +3.7% | 0.01% | -14.3% |
Q4 2019 | $2,231,000 | +83.8% | 105,432 | +15.2% | 0.01% | +75.0% |
Q3 2019 | $1,214,000 | -17.5% | 91,524 | -13.8% | 0.00% | -20.0% |
Q2 2019 | $1,472,000 | -24.0% | 106,127 | +5.3% | 0.01% | -28.6% |
Q1 2019 | $1,936,000 | +45.8% | 100,802 | +8.4% | 0.01% | +16.7% |
Q4 2018 | $1,328,000 | -27.4% | 93,012 | +5.9% | 0.01% | -14.3% |
Q3 2018 | $1,830,000 | -12.0% | 87,840 | 0.0% | 0.01% | -12.5% |
Q2 2018 | $2,079,000 | +59.3% | 87,840 | -1.6% | 0.01% | +33.3% |
Q1 2018 | $1,305,000 | +6.4% | 89,292 | +17.7% | 0.01% | +20.0% |
Q4 2017 | $1,226,000 | +15.4% | 75,865 | -0.1% | 0.01% | 0.0% |
Q3 2017 | $1,062,000 | +154.1% | 75,960 | +60.5% | 0.01% | +66.7% |
Q2 2017 | $418,000 | -30.2% | 47,325 | -48.9% | 0.00% | -25.0% |
Q1 2017 | $599,000 | – | 92,625 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |